Financhill
Sell
38

IHF Quote, Financials, Valuation and Earnings

Last price:
$45.18
Seasonality move :
0.55%
Day range:
$44.94 - $45.42
52-week range:
$44.62 - $58.94
Dividend yield:
0.99%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
203.5K
Avg. volume:
204.9K
1-year change:
-13.82%
Market cap:
--
Revenue:
--
EPS (TTM):
--

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
IHF
iShares US Healthcare Providers ETF
-- -- -- -- --
BBH
VanEck Biotech ETF
-- -- -- -- --
FXH
First Trust Health Care AlphaDEX Fund
-- -- -- -- --
IHE
iShares US Pharmaceuticals ETF
-- -- -- -- --
PJP
Invesco Pharmaceuticals ETF
-- -- -- -- --
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
-- -- -- -- --
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
IHF
iShares US Healthcare Providers ETF
$45.22 -- -- -- $0.06 0.99% --
BBH
VanEck Biotech ETF
$158.22 -- -- -- $1.25 0.79% --
FXH
First Trust Health Care AlphaDEX Fund
$102.23 -- -- -- $0.06 0.34% --
IHE
iShares US Pharmaceuticals ETF
$67.18 -- -- -- $0.31 1.74% --
PJP
Invesco Pharmaceuticals ETF
$82.48 -- -- -- $0.27 1.17% --
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
$29.02 -- -- -- $0.06 0.77% --
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
IHF
iShares US Healthcare Providers ETF
-- 0.813 -- --
BBH
VanEck Biotech ETF
-- 0.630 -- --
FXH
First Trust Health Care AlphaDEX Fund
-- 0.984 -- --
IHE
iShares US Pharmaceuticals ETF
-- 0.333 -- --
PJP
Invesco Pharmaceuticals ETF
-- 0.248 -- --
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
-- 0.851 -- --
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
IHF
iShares US Healthcare Providers ETF
-- -- -- -- -- --
BBH
VanEck Biotech ETF
-- -- -- -- -- --
FXH
First Trust Health Care AlphaDEX Fund
-- -- -- -- -- --
IHE
iShares US Pharmaceuticals ETF
-- -- -- -- -- --
PJP
Invesco Pharmaceuticals ETF
-- -- -- -- -- --
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
-- -- -- -- -- --

iShares US Healthcare Providers ETF vs. Competitors

  • Which has Higher Returns IHF or BBH?

    VanEck Biotech ETF has a net margin of -- compared to iShares US Healthcare Providers ETF's net margin of --. iShares US Healthcare Providers ETF's return on equity of -- beat VanEck Biotech ETF's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    IHF
    iShares US Healthcare Providers ETF
    -- -- --
    BBH
    VanEck Biotech ETF
    -- -- --
  • What do Analysts Say About IHF or BBH?

    iShares US Healthcare Providers ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand VanEck Biotech ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares US Healthcare Providers ETF has higher upside potential than VanEck Biotech ETF, analysts believe iShares US Healthcare Providers ETF is more attractive than VanEck Biotech ETF.

    Company Buy Ratings Hold Ratings Sell Ratings
    IHF
    iShares US Healthcare Providers ETF
    0 0 0
    BBH
    VanEck Biotech ETF
    0 0 0
  • Is IHF or BBH More Risky?

    iShares US Healthcare Providers ETF has a beta of 0.729, which suggesting that the stock is 27.109% less volatile than S&P 500. In comparison VanEck Biotech ETF has a beta of 0.764, suggesting its less volatile than the S&P 500 by 23.586%.

  • Which is a Better Dividend Stock IHF or BBH?

    iShares US Healthcare Providers ETF has a quarterly dividend of $0.06 per share corresponding to a yield of 0.99%. VanEck Biotech ETF offers a yield of 0.79% to investors and pays a quarterly dividend of $1.25 per share. iShares US Healthcare Providers ETF pays -- of its earnings as a dividend. VanEck Biotech ETF pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios IHF or BBH?

    iShares US Healthcare Providers ETF quarterly revenues are --, which are smaller than VanEck Biotech ETF quarterly revenues of --. iShares US Healthcare Providers ETF's net income of -- is lower than VanEck Biotech ETF's net income of --. Notably, iShares US Healthcare Providers ETF's price-to-earnings ratio is -- while VanEck Biotech ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares US Healthcare Providers ETF is -- versus -- for VanEck Biotech ETF. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    IHF
    iShares US Healthcare Providers ETF
    -- -- -- --
    BBH
    VanEck Biotech ETF
    -- -- -- --
  • Which has Higher Returns IHF or FXH?

    First Trust Health Care AlphaDEX Fund has a net margin of -- compared to iShares US Healthcare Providers ETF's net margin of --. iShares US Healthcare Providers ETF's return on equity of -- beat First Trust Health Care AlphaDEX Fund's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    IHF
    iShares US Healthcare Providers ETF
    -- -- --
    FXH
    First Trust Health Care AlphaDEX Fund
    -- -- --
  • What do Analysts Say About IHF or FXH?

    iShares US Healthcare Providers ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand First Trust Health Care AlphaDEX Fund has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares US Healthcare Providers ETF has higher upside potential than First Trust Health Care AlphaDEX Fund, analysts believe iShares US Healthcare Providers ETF is more attractive than First Trust Health Care AlphaDEX Fund.

    Company Buy Ratings Hold Ratings Sell Ratings
    IHF
    iShares US Healthcare Providers ETF
    0 0 0
    FXH
    First Trust Health Care AlphaDEX Fund
    0 0 0
  • Is IHF or FXH More Risky?

    iShares US Healthcare Providers ETF has a beta of 0.729, which suggesting that the stock is 27.109% less volatile than S&P 500. In comparison First Trust Health Care AlphaDEX Fund has a beta of 0.785, suggesting its less volatile than the S&P 500 by 21.471%.

  • Which is a Better Dividend Stock IHF or FXH?

    iShares US Healthcare Providers ETF has a quarterly dividend of $0.06 per share corresponding to a yield of 0.99%. First Trust Health Care AlphaDEX Fund offers a yield of 0.34% to investors and pays a quarterly dividend of $0.06 per share. iShares US Healthcare Providers ETF pays -- of its earnings as a dividend. First Trust Health Care AlphaDEX Fund pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios IHF or FXH?

    iShares US Healthcare Providers ETF quarterly revenues are --, which are smaller than First Trust Health Care AlphaDEX Fund quarterly revenues of --. iShares US Healthcare Providers ETF's net income of -- is lower than First Trust Health Care AlphaDEX Fund's net income of --. Notably, iShares US Healthcare Providers ETF's price-to-earnings ratio is -- while First Trust Health Care AlphaDEX Fund's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares US Healthcare Providers ETF is -- versus -- for First Trust Health Care AlphaDEX Fund. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    IHF
    iShares US Healthcare Providers ETF
    -- -- -- --
    FXH
    First Trust Health Care AlphaDEX Fund
    -- -- -- --
  • Which has Higher Returns IHF or IHE?

    iShares US Pharmaceuticals ETF has a net margin of -- compared to iShares US Healthcare Providers ETF's net margin of --. iShares US Healthcare Providers ETF's return on equity of -- beat iShares US Pharmaceuticals ETF's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    IHF
    iShares US Healthcare Providers ETF
    -- -- --
    IHE
    iShares US Pharmaceuticals ETF
    -- -- --
  • What do Analysts Say About IHF or IHE?

    iShares US Healthcare Providers ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares US Pharmaceuticals ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares US Healthcare Providers ETF has higher upside potential than iShares US Pharmaceuticals ETF, analysts believe iShares US Healthcare Providers ETF is more attractive than iShares US Pharmaceuticals ETF.

    Company Buy Ratings Hold Ratings Sell Ratings
    IHF
    iShares US Healthcare Providers ETF
    0 0 0
    IHE
    iShares US Pharmaceuticals ETF
    0 0 0
  • Is IHF or IHE More Risky?

    iShares US Healthcare Providers ETF has a beta of 0.729, which suggesting that the stock is 27.109% less volatile than S&P 500. In comparison iShares US Pharmaceuticals ETF has a beta of 0.574, suggesting its less volatile than the S&P 500 by 42.647%.

  • Which is a Better Dividend Stock IHF or IHE?

    iShares US Healthcare Providers ETF has a quarterly dividend of $0.06 per share corresponding to a yield of 0.99%. iShares US Pharmaceuticals ETF offers a yield of 1.74% to investors and pays a quarterly dividend of $0.31 per share. iShares US Healthcare Providers ETF pays -- of its earnings as a dividend. iShares US Pharmaceuticals ETF pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios IHF or IHE?

    iShares US Healthcare Providers ETF quarterly revenues are --, which are smaller than iShares US Pharmaceuticals ETF quarterly revenues of --. iShares US Healthcare Providers ETF's net income of -- is lower than iShares US Pharmaceuticals ETF's net income of --. Notably, iShares US Healthcare Providers ETF's price-to-earnings ratio is -- while iShares US Pharmaceuticals ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares US Healthcare Providers ETF is -- versus -- for iShares US Pharmaceuticals ETF. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    IHF
    iShares US Healthcare Providers ETF
    -- -- -- --
    IHE
    iShares US Pharmaceuticals ETF
    -- -- -- --
  • Which has Higher Returns IHF or PJP?

    Invesco Pharmaceuticals ETF has a net margin of -- compared to iShares US Healthcare Providers ETF's net margin of --. iShares US Healthcare Providers ETF's return on equity of -- beat Invesco Pharmaceuticals ETF's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    IHF
    iShares US Healthcare Providers ETF
    -- -- --
    PJP
    Invesco Pharmaceuticals ETF
    -- -- --
  • What do Analysts Say About IHF or PJP?

    iShares US Healthcare Providers ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Pharmaceuticals ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares US Healthcare Providers ETF has higher upside potential than Invesco Pharmaceuticals ETF, analysts believe iShares US Healthcare Providers ETF is more attractive than Invesco Pharmaceuticals ETF.

    Company Buy Ratings Hold Ratings Sell Ratings
    IHF
    iShares US Healthcare Providers ETF
    0 0 0
    PJP
    Invesco Pharmaceuticals ETF
    0 0 0
  • Is IHF or PJP More Risky?

    iShares US Healthcare Providers ETF has a beta of 0.729, which suggesting that the stock is 27.109% less volatile than S&P 500. In comparison Invesco Pharmaceuticals ETF has a beta of 0.502, suggesting its less volatile than the S&P 500 by 49.771%.

  • Which is a Better Dividend Stock IHF or PJP?

    iShares US Healthcare Providers ETF has a quarterly dividend of $0.06 per share corresponding to a yield of 0.99%. Invesco Pharmaceuticals ETF offers a yield of 1.17% to investors and pays a quarterly dividend of $0.27 per share. iShares US Healthcare Providers ETF pays -- of its earnings as a dividend. Invesco Pharmaceuticals ETF pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios IHF or PJP?

    iShares US Healthcare Providers ETF quarterly revenues are --, which are smaller than Invesco Pharmaceuticals ETF quarterly revenues of --. iShares US Healthcare Providers ETF's net income of -- is lower than Invesco Pharmaceuticals ETF's net income of --. Notably, iShares US Healthcare Providers ETF's price-to-earnings ratio is -- while Invesco Pharmaceuticals ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares US Healthcare Providers ETF is -- versus -- for Invesco Pharmaceuticals ETF. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    IHF
    iShares US Healthcare Providers ETF
    -- -- -- --
    PJP
    Invesco Pharmaceuticals ETF
    -- -- -- --
  • Which has Higher Returns IHF or RSPH?

    Invesco S&P 500 Eql Wght Health Care ETF has a net margin of -- compared to iShares US Healthcare Providers ETF's net margin of --. iShares US Healthcare Providers ETF's return on equity of -- beat Invesco S&P 500 Eql Wght Health Care ETF's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    IHF
    iShares US Healthcare Providers ETF
    -- -- --
    RSPH
    Invesco S&P 500 Eql Wght Health Care ETF
    -- -- --
  • What do Analysts Say About IHF or RSPH?

    iShares US Healthcare Providers ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco S&P 500 Eql Wght Health Care ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares US Healthcare Providers ETF has higher upside potential than Invesco S&P 500 Eql Wght Health Care ETF, analysts believe iShares US Healthcare Providers ETF is more attractive than Invesco S&P 500 Eql Wght Health Care ETF.

    Company Buy Ratings Hold Ratings Sell Ratings
    IHF
    iShares US Healthcare Providers ETF
    0 0 0
    RSPH
    Invesco S&P 500 Eql Wght Health Care ETF
    0 0 0
  • Is IHF or RSPH More Risky?

    iShares US Healthcare Providers ETF has a beta of 0.729, which suggesting that the stock is 27.109% less volatile than S&P 500. In comparison Invesco S&P 500 Eql Wght Health Care ETF has a beta of 0.880, suggesting its less volatile than the S&P 500 by 11.971%.

  • Which is a Better Dividend Stock IHF or RSPH?

    iShares US Healthcare Providers ETF has a quarterly dividend of $0.06 per share corresponding to a yield of 0.99%. Invesco S&P 500 Eql Wght Health Care ETF offers a yield of 0.77% to investors and pays a quarterly dividend of $0.06 per share. iShares US Healthcare Providers ETF pays -- of its earnings as a dividend. Invesco S&P 500 Eql Wght Health Care ETF pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios IHF or RSPH?

    iShares US Healthcare Providers ETF quarterly revenues are --, which are smaller than Invesco S&P 500 Eql Wght Health Care ETF quarterly revenues of --. iShares US Healthcare Providers ETF's net income of -- is lower than Invesco S&P 500 Eql Wght Health Care ETF's net income of --. Notably, iShares US Healthcare Providers ETF's price-to-earnings ratio is -- while Invesco S&P 500 Eql Wght Health Care ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares US Healthcare Providers ETF is -- versus -- for Invesco S&P 500 Eql Wght Health Care ETF. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    IHF
    iShares US Healthcare Providers ETF
    -- -- -- --
    RSPH
    Invesco S&P 500 Eql Wght Health Care ETF
    -- -- -- --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will Microsoft Be a $5 Trillion Stock?
Will Microsoft Be a $5 Trillion Stock?

Microsoft’s market capitalization sits near $3.73 trillion today. To clear the…

Where Will C3.ai Stock Be in 1 Year?
Where Will C3.ai Stock Be in 1 Year?

C3 .ai (NYSE: AI) has been the poster child for “hype versus execution.”…

What Is the Ceiling for IONQ Stock?
What Is the Ceiling for IONQ Stock?

IonQ (NYSE:IONQ) is a quantum computing startup that, like many…

Stock Ideas

Buy
69
Is NVDA Stock a Buy?

Market Cap: $4T
P/E Ratio: 56x

Buy
62
Is MSFT Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 43x

Sell
45
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Alerts

Buy
58
INKT alert for Jul 12

MiNK Therapeutics [INKT] is up 727.94% over the past day.

Buy
51
NEGG alert for Jul 12

Newegg Commerce [NEGG] is up 74.03% over the past day.

Buy
68
ATRO alert for Jul 12

Astronics [ATRO] is up 16.28% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock